FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roy Jones

Research Profile

Procedures

Disorders

Breast Neoplasms

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
L M Poon; U R Popat; Muzaffar H Qazilbash; Gabriela Rondon; Elizabeth J Shpall; Laura L Worth; Yago Nieto; R Bassett; Richard E Champlin; L Cooper; Marcos De Lima; A Hamdi; Chitra Hosing; Roy B Jones; Partow Kebriaei
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Gabriela Rondon; Nina Shah; Elizabeth J Shpall; Benigno C Valdez; Amin Alousi; Paolo Anderlini; Borje Andersson; Qaiser Bashir; Richard Champlin; Chitra Hosing; Partow Kebriaei; Issa Khouri; Ping Liu; Roy B Jones
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
Partow Kebriaei; C Ledesma; T Madden; Yago Nieto; Uday Popat; Muzaffar H Qazilbash; Elizabeth J Shpall; P F Thall; X Wang; Richard E Champlin; Marcos De Lima; Chitra Hosing; Roy B Jones; Amin Alousi; Borje S Andersson
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roy Jones (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L M Poon; U R Popat; Muzaffar H Qazilbash; Gabriela Rondon; Elizabeth J Shpall; Laura L Worth; Yago Nieto; R Bassett; Richard E Champlin; L Cooper; Marcos De Lima; A Hamdi; Chitra Hosing; Roy B Jones; Partow Kebriaei
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
Bone marrow transplantation 2013;48(5):666-70.
2013: Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Gabriela Rondon; Nina Shah; Elizabeth J Shpall; Benigno C Valdez; Amin Alousi; Paolo Anderlini; Borje Andersson; Qaiser Bashir; Richard Champlin; Chitra Hosing; Partow Kebriaei; Issa Khouri; Ping Liu; Roy B Jones
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):410-7.
2013: Partow Kebriaei; C Ledesma; T Madden; Yago Nieto; Uday Popat; Muzaffar H Qazilbash; Elizabeth J Shpall; P F Thall; X Wang; Richard E Champlin; Marcos De Lima; Chitra Hosing; Roy B Jones; Amin Alousi; Borje S Andersson
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Bone marrow transplantation 2013;48(1):26-31.
2012: Partow Kebriaei; Issa Khouri; C Ledesma; Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Elizabeth J Shpall; Roland Basset; Richard E Champlin; S Ciurea; Marcos De Lima; Chitra Hosing; Roy B Jones; Amin Alousi; Borje S Andersson
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1819-26.
2012: Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Gabriela Rondon; Nina Shah; Elizabeth J Shpall; Peter Thall; Benigno C Valdez; Laura Worth; Amin Alousi; Paolo Anderlini; Borje Andersson; Qaiser Bashir; Roland Bassett; Richard Champlin; Christina Chancoco; Stefan Ciurea; Erin Frazier; Alison Gulbis; Chitra Hosing; Partow Kebriaei; Issa Khouri; Roy B Jones
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1677-86.
2011: Alison M Gulbis; Roy B Jones; Kirk S Culotta; Borje S Andersson
Busulfan and metronidazole: an often forgotten but significant drug interaction.
The Annals of pharmacotherapy 2011;45(7-8):e39.
2011: Borje S Andersson; Benigno C Valdez; Marcos De Lima; Xuemei Wang; Peter F Thall; Laura L Worth; Uday Popat; Timothy Madden; Chitra Hosing; Amin Alousi; Gabriela Rondon; Partow Kebriaei; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):893-900.
2011: Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F Thall; Celina Ledesma; Yago Nieto; Elizabeth J Shpall; Chitra Hosing; Muzaffar H Qazilbash; Uday Popat; Issa Khouri; Richard E Champlin; Roy B Jones; Borje S Andersson
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):412-20.
2011: Simrit Parmar; Borje S Andersson; Daniel Couriel; Mark F Munsell; Marcelo Fernandez-Vina; Roy B Jones; Elizabeth J Shpall; Uday Popat; Paolo Anderlini; Sergio Giralt; Amin Alousi; Pedro Cano; Doyle Bosque; Chitra Hosing; Leandro de Padua Silva; Michael Westmoreland; J Kyle Wathen; Donald Berry; Richard E Champlin; Marcos J de Lima
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(3):294-302.
2010: Marcos De Lima; Sergio Giralt; Peter F Thall; Leandro de Padua Silva; Roy B Jones; Krishna Komanduri; Thomas M Braun; Hoang Q Nguyen; Richard Champlin; Guillermo Garcia-Manero
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.
Cancer 2010;116(23):5420-31.
2010: S O Ciurea; Rima M Saliba; Gabriela Rondon; Susana Pesoa; Pedro Cano; Marcelo Fernandez-Vina; S Qureshi; Laura L Worth; John McMannis; Partow Kebriaei; Roy B Jones; Martin Korbling; Muzaffar H Qazilbash; Elizabeth J Shpall; Sergio Giralt; M de Lima; Richard E Champlin; James L Gajewski
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
Bone marrow transplantation 2010;45(3):429-36.
2009: J A de Souza; M L Davis; Gabriela Rondon; Yee Chung Cheng; Roy B Jones; Richard E Champlin; Naoto T Ueno
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
Bone marrow transplantation 2009;44(2):81-7.
2009: Roy B Jones; Yago Nieto; Donna Wall; John R Wingard; J Douglas Rizzo; Philip L McCarthy; Denise Oliansky; Theresa Hahn
Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):761-2.
2008: Muzaffar H Qazilbash; Rima M Saliba; Yago Nieto; Gaurav Parikh; Matteo Pelosini; Fatima B Khan; Roy B Jones; Chitra Hosing; Floralyn Mendoza; Donna M Weber; Michael Wang; Uday Popat; Amin Alousi; Paolo Anderlini; Richard E Champlin; Sergio Giralt
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1401-7.
2008: Borje S Andersson; Marcos De Lima; Peter F Thall; Xuemei Wang; Daniel Couriel; Martin Korbling; Soonja Roberson; Sergio Giralt; Betty Pierre; James A Russell; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
2007: Yago Nieto; Fatima Nawaz; Roy B Jones; Elizabeth J Shpall; Samia Nawaz
Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4405-13.
2007: Timothy Madden; Marcos De Lima; Neil Thapar; John Nguyen; Soonja Roberson; Daniel Couriel; Betty Pierre; Elizabeth J Shpall; Roy B Jones; Richard E Champlin; Borje S Andersson
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):56-64.
2006: Yago Nieto; Nigel Patton; Timothy Hawkins; Ruth Spearing; Scott I Bearman; Roy B Jones; Elizabeth J Shpall; Rachel Rabinovitch; Chan Zeng; Anna E Barón; Peter A McSweeney
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):217-25.
2005: J A Gutman; Scott I Bearman; Yago Nieto; John Sweetenham; Roy B Jones; Elizabeth J Shpall; Chan Zeng; A Baron; Peter A McSweeney
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study.
Bone marrow transplantation 2005;36(5):443-51.
2005: Yago Nieto; Elizabeth J Shpall; Scott I Bearman; Roy B Jones
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.
American journal of clinical oncology 2005;28(3):248-54.
2005: Yago Nieto; Elizabeth J Shpall; Scott I Bearman; Peter A McSweeney; Pablo J Cagnoni; Steven G Matthes; Dan Gustafson; Michael Long; Anna E Barón; Roy B Jones
Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):297-306.
2004: Yago Nieto; James J Vredenburgh; Elizabeth J Shpall; Scott I Bearman; Peter A McSweeney; Nelson Chao; David A Rizzieri; Cristina Gasparetto; Steven G Matthes; Anna E Barón; Roy B Jones
Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7136-43.
2004: Yago Nieto; Roy B Jones; Elizabeth J Shpall
Stem-cell transplantation for the treatment of advanced solid tumors.
Springer seminars in immunopathology 2004;26(1-2):31-56.
2004: Yago Nieto; Elizabeth J Shpall; Ian K McNiece; Samia Nawaz; Julie Beaudet; Steve Rosinski; Julie Pellom; Vicki Slat-Vasquez; Peter A McSweeney; Scott I Bearman; James Murphy; Roy B Jones
Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5076-86.
2004: Yago Nieto; Wilbur A Franklin; Roy B Jones; Scott I Berman; Julie Pellom; Anna E Barón; Elizabeth J Shpall
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):415-25.
2004: Yago Nieto; Samia Nawaz; Elizabeth J Shpall; Scott I Bearman; James Murphy; Roy B Jones
Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2609-17.
2004: Roy B Jones; Keith E Stockerl-Goldstein; Jared Klein; James Murphy; Karl G Blume; Roger Dansey; Charles Martinez; Steven G Matthes; Yago Nieto
A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(4):276-82.
2004: Yago Nieto; Roy B Jones; Elizabeth J Shpall
High-dose chemotherapy for breast cancer: is another look warranted?
Current opinion in oncology 2004;16(2):114-9.
2003: Bruno C Medeiros; J Fred Kolhouse; Pablo J Cagnoni; John Ryder; Yago Nieto; Rachel Rabinovitch; Elizabeth J Shpall; Scott I Bearman; Roy B Jones; Peter A McSweeney
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
Bone marrow transplantation 2003;31(11):1053-5.
2003: Benjamin T Suratt; Carlyne D Cool; Roy B Jones; D A Lynch; Kevin K Brown
Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
Bone marrow transplantation 2003;31(10):939-41.
2002: chirag parikh; Peter A McSweeney; Didem Korular Tez; Tevfik Ecder; Aicha Merouani; Jeremy Taylor; Vicki Slat-Vasquez; Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Robert W Schrier
Renal dysfunction in allogeneic hematopoietic cell transplantation.
Kidney international 2002;62(2):566-73.
2002: Timothy K Johnson; William Cole; Robert A Quaife; James L Lear; Roberto L Ceriani; Roy B Jones; Pablo J Cagnoni
Biokinetics of yttrium-90--labeled huBrE-3 monoclonal antibody.
Cancer 2002;94(4 Suppl):1240-8.
2002: Yago Nieto; Samia Nawaz; Roy B Jones; Elizabeth J Shpall; Pablo J Cagnoni; Peter A McSweeney; Anna E Barón; Carrington Razook; Steven G Matthes; Scott I Bearman
Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):707-18.
2002: Yago Nieto; Roy B Jones
DNA-binding agents.
Cancer chemotherapy and biological response modifiers 2002;20():197-225.
2002: Roy B Jones
Clinical pharmacology of melphalan and its implications for clinical resistance to anticancer agents.
Cancer treatment and research 2002;112():305-22.
2002: Elizabeth J Shpall; Ralph Quinones; Roger Giller; Chan Zeng; Anna E Baron; Roy B Jones; Scott I Bearman; Yago Nieto; Brian M Freed; Nancy Madinger; Christopher J Hogan; Vicki Slat-Vasquez; Peggy Russell; Betsy Blunk; Debra Schissel; Elaine Hild; Janet Malcolm; William Ward; Ian K McNiece
Transplantation of ex vivo expanded cord blood.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):368-76.
2002: Borje S Andersson; Ashwin Kashyap; Victor Gian; John R Wingard; Hugo Fernandez; Pablo J Cagnoni; Roy B Jones; stefano r tarantolo; Wendy W Hu; Karl G Blume; Stephen J Forman; Richard E Champlin
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):145-54.
2001: Yago Nieto; Scott I Bearman; Elizabeth J Shpall; Roy B Jones; Pablo J Cagnoni; Rachel Rabinovitch; Peter A McSweeney
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.
Bone marrow transplantation 2001;28(11):1083-6.
2001: Yago Nieto; Roy B Jones
DNA-binding agents.
Cancer chemotherapy and biological response modifiers 2001;19():189-213.
2000: Yago Nieto; Paul Russ; Gregory T Everson; Scott I Bearman; Pablo J Cagnoni; Roy B Jones; Elizabeth J Shpall
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation.
Bone marrow transplantation 2000;26(1):109-11.
2000: Yago Nieto; Pablo J Cagnoni; Samia Nawaz; Elizabeth J Shpall; R Yerushalmi; B Cook; P Russell; J McDermit; James Murphy; Scott I Bearman; Roy B Jones
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2070-80.
2000: Yago Nieto; R E Champlin; J R Wingard; J F Vredenburgh; Anthony D Elias; Paul Richardson; J Glaspy; Roy B Jones; Patrick J Stiff; Scott I Bearman; Pablo J Cagnoni; Peter A McSweeney; Charles F LeMaistre; Andrew L Pecora; E F Shpall
Status of high-dose chemotherapy for breast cancer: a review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(5):476-95.
2000: Yago Nieto; Pablo J Cagnoni; Scott I Bearman; Elizabeth J Shpall; Steven G Matthes; Roy B Jones
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):198-203.
1999: Yago Nieto; Pablo J Cagnoni; Elizabeth J Shpall; X Xu; James Murphy; James J Vredenburgh; Nelson J Chao; Scott I Bearman; Roy B Jones
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3425-31.
1999: D W Johnson; Pablo J Cagnoni; T M Schossau; S M Stemmer; D E Grayeb; Anna E Baron; Elizabeth J Shpall; Scott I Bearman; J McDermitt; Roy B Jones
Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.
Bone marrow transplantation 1999;24(7):785-92.
1999: Pablo J Cagnoni; Steven G Matthes; T C Day; Scott I Bearman; Elizabeth J Shpall; Roy B Jones
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
Bone marrow transplantation 1999;24(1):1-4.
1999: Yago Nieto; Pablo J Cagnoni; Elizabeth J Shpall; Steven G Matthes; Anna E Barón; Roy B Jones; Scott I Bearman
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1731-7.
1999: W A Franklin; J Glaspy; S M Pflaumer; Roy B Jones; LS Hami; C Martinez; J R Murphy; Elizabeth J Shpall
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.
Blood 1999;94(1):340-7.
1999: Yago Nieto; M Ross; Roberto Gianani; Elizabeth J Shpall; Pablo J Cagnoni; Scott I Bearman; Roy B Jones
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
Bone marrow transplantation 1999;23(12):1323-4.
1999: Yago Nieto; X Xu; Pablo J Cagnoni; Steven G Matthes; Elizabeth J Shpall; Scott I Bearman; James Murphy; Roy B Jones
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):747-51.
1999: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Pablo J Cagnoni; Yago Nieto; Ian K McNiece
Peripheral blood stem cell transplantation in breast cancer.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):219-32.
1999: Yago Nieto; Pablo J Cagnoni; Scott I Bearman; Elizabeth J Shpall; Steven G Matthes; T DeBoom; Anna E Barón; Roy B Jones
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):501-6.
1998: Pablo J Cagnoni; Yago Nieto; Elizabeth J Shpall; Scott I Bearman; Anna E Barón; M Ross; Steven G Matthes; S E Dunbar; Roy B Jones
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1661-8.
1998: M S Brown; S M Stemmer; Jack H Simon; JC Stears; Roy B Jones; Pablo J Cagnoni; Jeanelle Sheeder
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
AJNR. American journal of neuroradiology 1998;19(2):217-21.
1997: Scott I Bearman; Beth Overmoyer; B J Bolwell; C W Taylor; Elizabeth J Shpall; Pablo J Cagnoni; B E Mechling; B Ronk; Anna E Barón; M H Purdy; M Ross; Roy B Jones
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
Bone marrow transplantation 1997;20(11):931-7.
1997: Elizabeth J Shpall; Charles F LeMaistre; K Holland; E Ball; Roy B Jones; R Saral; C Jacobs; S Heimfeld; R Berenson; Richard Champlin
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.
Blood 1997;90(11):4313-20.
1997: Elizabeth J Shpall; Pablo J Cagnoni; Scott I Bearman; M Ross; Yago Nieto; Roy B Jones
Peripheral blood stem cell harvesting and CD34-positive cell selection.
Cancer treatment and research 1997;77():143-57.
1997: Elizabeth J Shpall; Pablo J Cagnoni; Scott I Bearman; M Ross; Roy B Jones
Peripheral blood stem cells for autografting.
Annual review of medicine 1997;48():241-51.
1996: Pablo J Cagnoni; Elizabeth J Shpall; Scott I Bearman; Steven G Matthes; M Ross; S Taffs; Roy B Jones
Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience.
Seminars in oncology 1996;23(6 Suppl 15):43-8.
1996: Pablo J Cagnoni; Elizabeth J Shpall; Scott I Bearman; M Ross; Roy B Jones
High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results.
Bone marrow transplantation 1996;18 Suppl 1():S26-9.
1996: Aicha Merouani; Elizabeth J Shpall; Roy B Jones; P G Archer; Robert W Schrier
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Kidney international 1996;50(3):1026-31.
1996: Pablo J Cagnoni; Roy B Jones; Scott I Bearman; M Ross; LS Hami; Wilbur A Franklin; R Capizzi; P S Schein; Elizabeth J Shpall
Use of amifostine in bone marrow purging.
Seminars in oncology 1996;23(4 Suppl 8):44-8.
1996: S M Stemmer; Pablo J Cagnoni; Elizabeth J Shpall; Scott I Bearman; Steven G Matthes; C Dufton; T Day; S Taffs; LS Hami; C Martinez; M H Purdy; J Arron; Roy B Jones
High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1463-72.
1996: Elizabeth J Shpall; A P Gee; Christopher J Hogan; Pablo J Cagnoni; U Gehling; LS Hami; W Franklin; Scott I Bearman; M Ross; Roy B Jones
Bone marrow metastases.
Hematology/oncology clinics of North America 1996;10(2):321-43.
1996: Scott I Bearman; Elizabeth J Shpall; Roy B Jones; Pablo J Cagnoni; M Ross
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.
Seminars in oncology 1996;23(1 Suppl 2):60-7.
1996: Wilbur A Franklin; Elizabeth J Shpall; P Archer; C S Johnston; S Garza-Williams; LS Hami; Mitchell A Bitter; R C Bast; Roy B Jones
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Breast cancer research and treatment 1996;41(1):1-13.
1995: M H Purdy; Christopher J Hogan; LS Hami; Ian K McNiece; W Franklin; Roy B Jones; Scott I Bearman; R J Berenson; Pablo J Cagnoni; S Heimfeld
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
Journal of hematotherapy 1995;4(6):515-25.
1995: Elizabeth J Shpall; A Gee; Pablo J Cagnoni; Christopher J Hogan; U Gehling; LS Hami; W Franklin; Scott I Bearman; M Ross; Roy B Jones
Stem cell isolation.
Current opinion in hematology 1995;2(6):452-9.
1995: M S Brown; Jack H Simon; S M Stemmer; JC Stears; Ann L Scherzinger; Pablo J Cagnoni; Roy B Jones
MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma.
AJNR. American journal of neuroradiology 1995;16(10):2013-20.
1994: S M Stemmer; JC Stears; B S Burton; Roy B Jones; Jack H Simon
White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support.
AJNR. American journal of neuroradiology 1994;15(7):1267-73.
1994: Roy B Jones; Steven G Matthes; D Kemme; C Dufton; S Kernan
Cyclophosphamide, cisplatin, and carmustine: pharmacokinetics of carmustine following multiple alkylating-agent interactions.
Cancer chemotherapy and pharmacology 1994;35(1):59-63.
1994: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; M H Purdy; Wilbur A Franklin; S Heimfeld; R J Berenson
Transplantation of CD34+ hematopoietic progenitor cells.
Journal of hematotherapy 1994;3(2):145-7.
1994: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Wilbur A Franklin; P G Archer; Tyler J Curiel; Mitchell A Bitter; H N Claman; S M Stemmer; M Purdy
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):28-36.
1993: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; S M Stemmer; M H Purdy; S Heimfeld; R J Berenson
Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():48-9.
1993: Elizabeth J Shpall; S M Stemmer; Scott I Bearman; Roy B Jones
Role of autotransplantation in treatment of other solid tumors.
Hematology/oncology clinics of North America 1993;7(3):663-86.
1993: Roy B Jones; Steven G Matthes; Elizabeth J Shpall; J H Fisher; S M Stemmer; C Dufton; JK Stephens; Scott I Bearman
Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
Journal of the National Cancer Institute 1993;85(8):640-7.
1993: S M Stemmer; K Kinsman; S Tellschow; Roy B Jones
Fatal noncutaneous visceral infection with varicella-zoster virus in a patient with lymphoma after autologous bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(4):497-9.
1993: Roy B Jones; Steven G Matthes; C Dufton; Scott I Bearman; S M Stemmer; S Meyers; Elizabeth J Shpall
Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer.
Breast cancer research and treatment 1993;26 Suppl():S11-7.
1993: Elizabeth J Shpall; S M Stemmer; Scott I Bearman; S Myers; M Purdy; Roy B Jones
New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.
Breast cancer research and treatment 1993;26 Suppl():S19-23.
1992: C S Johnston; Elizabeth J Shpall; S Williams; LS Hami; Roy B Jones; R C Bast; R L Ceriani; W Franklin
Detection of minimal residual breast cancer in bone marrow.
Progress in clinical and biological research 1992;377():637-42.
1992: Elizabeth J Shpall; S M Stemmer; C F Johnston; LS Hami; Scott I Bearman; R Berenson; Roy B Jones
Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
Journal of hematotherapy 1992;1(1):45-54.
1992: LS Hami; Elizabeth J Shpall; C S Johnston; R Berenson; Roy B Jones
The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow.
Progress in clinical and biological research 1992;377():321-5.